The history of Sildenafil presents a challenging picture for shareholders. While the initial launch generated massive returns, the expiration of its intellectual property protection opened the door to cheaper versions, https://iwancekc790756.blogzet.com/sildenafil-and-pharma-a-risky-investment-56911332